Global Monoclonal Antibody Therapeutics Market Growth (Status and Outlook) 2024-2030

2024

Global Monoclonal Antibody Therapeutics Market Growth (Status and Outlook) 2024-2030

Name: Global Monoclonal Antibody Therapeutics Market Growth (Status and Outlook) 2024-2030
Brand: Bonafide Research
SKU: 95001413
Price: 3450 USD
Availability: InStock
Rating: 5 (14.85 reviews)

The global Monoclonal Antibody Therapeutics market, valued at US$ 111,700 million in 2023, is projected to grow as demand for antibody-based therapies increases in oncology and aut

Bonafide Trust
05-09-2024
Pages : 112
Figures : 85
Tables : 110
Region : Global
Category : Lifescience & Healthcare
Healthcare

Schedule a Call

Buy Now Get Free sample

Request new version

Request for updated version of the report at the same price

Order Now

The global monoclonal antibody therapeutics market is a rapidly growing segment of the biopharmaceutical industry, valued at approximately USD 252.6 billion in 2024 and projected to reach USD 497.5 billion by 2029, growing at a compound annual growth rate (CAGR) of around 14.5% from 2024 to 2029. Monoclonal antibodies (mAbs) are laboratory-made molecules engineered to serve as substitute antibodies that can restore, enhance, or mimic the immune system's attack on harmful cells. These therapeutics are used to treat a variety of diseases, including cancer, autoimmune disorders, and infectious diseases, due to their ability to target specific cells with high precision. The market is driven by factors such as the increasing prevalence of chronic diseases, advancements in biotechnology and genetic engineering, and robust investments in research and development. Clinical trials play a pivotal role in validating the efficacy, safety, and commercial viability of mAbs, further driving market growth. Additionally, the introduction of biosimilars and reimbursement strategies is addressing pricing concerns and promoting market expansion. The ongoing COVID-19 pandemic has underscored the potential of mAbs in infectious diseases, leading to expanded applications and increased demand. Significant opportunities lie in biosimilar development, innovative delivery systems, and the emerging field of antibody-drug conjugates. However, the market faces challenges such as high production costs, stringent regulatory pathways, and intellectual property issues. Addressing these challenges requires strategic planning, innovation, and collaboration within the industry to ensure the development of cost-effective, compliant, and effective monoclonal antibody therapeutics. The research report highlights the growth potential of the global Monoclonal Antibody Therapeutics market. Monoclonal Antibody Therapeutics are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Monoclonal Antibody Therapeutics. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Monoclonal Antibody Therapeutics market.

According to Publisher, the global Monoclonal Antibody Therapeutics market size was valued at US$ 111700 million in 2023. With growing demand in downstream market, the Monoclonal Antibody Therapeutics is forecast to a readjusted size of US$ 183700 million by 2030 with a CAGR of 7.4% during review period. The global monoclonal antibody therapeutics market is driven by several key factors, including the increasing prevalence of chronic diseases, advancements in biotechnology and genetic engineering, robust investments in research and development, and expanding applications in infectious diseases. Chronic diseases such as cancer, autoimmune disorders, and diabetes are on the rise, creating a significant demand for targeted therapies like monoclonal antibodies. Innovations in biotechnology and genetic engineering have enabled the development of more effective and precise monoclonal antibodies, enhancing their therapeutic potential. Additionally, substantial investments in research and development are fueling the discovery of new monoclonal antibody treatments and expanding their applications. The COVID-19 pandemic has also highlighted the importance of monoclonal antibodies in treating infectious diseases, leading to increased research and development efforts in this area. These factors collectively contribute to the growth and expansion of the global monoclonal antibody therapeutics market, ensuring the development of innovative and effective treatments for various medical conditions. The research report provide an overview of the current size and growth of the Monoclonal Antibody Therapeutics market. It may include historical data, market segmentation by Type (e.g., Humanized Antibody, Human Mouse Chimeric Antibody), and regional breakdowns.

What's Inside a Bonafide Research`s industry report?

A Bonafide Research industry report provides in-depth market analysis, trends, competitive insights, and strategic recommendations to help businesses make informed decisions.

Download Sample

The global monoclonal antibody therapeutics market is segmented by type into fully human, humanized, chimeric, and other types. Fully human monoclonal antibodies are derived from human immune cells and are designed to minimize immune reactions, making them highly effective for therapeutic use. Humanized monoclonal antibodies are produced by combining human and non-human components, retaining the specificity of the original antibody while reducing the risk of immune responses. Chimeric monoclonal antibodies are created by fusing human and animal antibody genes, offering a balance between efficacy and reduced immunogenicity. The "other types" category includes novel formats such as bispecific antibodies, antibody-drug conjugates, and antibody fragments, which are engineered for specific therapeutic targets and applications2. Each type of monoclonal antibody has unique properties and applications, contributing to the overall growth and versatility of the global monoclonal antibody therapeutics market.

The global monoclonal antibody therapeutics market is segmented by application into oncology, autoimmune diseases, infectious diseases, and others. The oncology segment is the largest and fastest-growing, driven by the increasing prevalence of cancer and the development of targeted therapies that improve patient outcomes. Monoclonal antibodies are used to treat various types of cancer by targeting specific cancer cells and minimizing damage to healthy cells. The autoimmune diseases segment includes conditions such as rheumatoid arthritis, multiple sclerosis, and inflammatory bowel disease, where monoclonal antibodies help modulate the immune system to reduce inflammation and disease progression. The infectious diseases segment has gained significant attention, especially with the development of monoclonal antibodies for COVID-19 treatment, showcasing their potential in combating viral infections. The "others" category encompasses applications in conditions like cardiovascular diseases and neurological disorders, where monoclonal antibodies are being explored for their therapeutic benefits. Each application segment highlights the versatility and critical role of monoclonal antibodies in addressing a wide range of medical conditions, supporting the overall growth of the global market.

The regional analysis of the global monoclonal antibody therapeutics market reveals distinct trends and growth patterns across different geographical areas, highlighting its critical role in supporting regional economic development. The North American region dominates the market, driven by advanced healthcare infrastructure, high research and development investments, and a strong focus on innovation. The United States and Canada are leading contributors, with numerous biopharmaceutical companies actively involved in monoclonal antibody research and commercialization. The European region follows closely, with countries like Germany, France, and the United Kingdom making significant strides in the development and approval of monoclonal antibody therapies. The Asia-Pacific region is emerging as a key player, with rapid economic growth, increasing healthcare expenditure, and a growing patient population driving market expansion. Countries like China, Japan, and India are investing heavily in biotechnology and pharmaceutical research, leading to the development of novel monoclonal antibody treatments. The Latin American and Middle Eastern & African regions are also witnessing growth, albeit at a slower pace, due to challenges such as limited healthcare infrastructure and regulatory hurdles. However, increasing awareness of advanced therapies and collaborations with international pharmaceutical companies are expected to boost market growth in these regions. Each region presents unique opportunities and challenges, with regional players adapting to local market conditions and regulatory environments to drive growth and innovation in the global monoclonal antibody therapeutics market.

Make this report your own

Have queries/questions regarding a report

Take advantage of intelligence tailored to your business objective

Sikandar Kesari

Research Analyst

Don’t pay for what you don’t need. Save 30%

Customise your report by selecting specific countries or regions

Specify Scope Now

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Monoclonal Antibody Therapeutics Market Size 2019-2030
2.1.2 Monoclonal Antibody Therapeutics Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Monoclonal Antibody Therapeutics Segment by Type
2.2.1 Humanized Antibody
2.2.2 Human Mouse Chimeric Antibody
2.3 Monoclonal Antibody Therapeutics Market Size by Type
2.3.1 Monoclonal Antibody Therapeutics Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Monoclonal Antibody Therapeutics Market Size Market Share by Type (2019-2024)
2.4 Monoclonal Antibody Therapeutics Segment by Application
2.4.1 Cancer
2.4.2 Autoimmune Diseases
2.4.3 Infection
2.4.4 Hematological Diseases
2.4.5 Ophthalmological Diseases
2.4.6 Others
2.5 Monoclonal Antibody Therapeutics Market Size by Application
2.5.1 Monoclonal Antibody Therapeutics Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Monoclonal Antibody Therapeutics Market Size Market Share by Application (2019-2024)
3 Monoclonal Antibody Therapeutics Market Size by Player
3.1 Monoclonal Antibody Therapeutics Market Size Market Share by Players
3.1.1 Global Monoclonal Antibody Therapeutics Revenue by Players (2019-2024)
3.1.2 Global Monoclonal Antibody Therapeutics Revenue Market Share by Players (2019-2024)
3.2 Global Monoclonal Antibody Therapeutics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Monoclonal Antibody Therapeutics by Regions
4.1 Monoclonal Antibody Therapeutics Market Size by Regions (2019-2024)
4.2 Americas Monoclonal Antibody Therapeutics Market Size Growth (2019-2024)
4.3 APAC Monoclonal Antibody Therapeutics Market Size Growth (2019-2024)
4.4 Europe Monoclonal Antibody Therapeutics Market Size Growth (2019-2024)
4.5 Middle East & Africa Monoclonal Antibody Therapeutics Market Size Growth (2019-2024)
5 Americas
5.1 Americas Monoclonal Antibody Therapeutics Market Size by Country (2019-2024)
5.2 Americas Monoclonal Antibody Therapeutics Market Size by Type (2019-2024)
5.3 Americas Monoclonal Antibody Therapeutics Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Monoclonal Antibody Therapeutics Market Size by Region (2019-2024)
6.2 APAC Monoclonal Antibody Therapeutics Market Size by Type (2019-2024)
6.3 APAC Monoclonal Antibody Therapeutics Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Monoclonal Antibody Therapeutics by Country (2019-2024)
7.2 Europe Monoclonal Antibody Therapeutics Market Size by Type (2019-2024)
7.3 Europe Monoclonal Antibody Therapeutics Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Monoclonal Antibody Therapeutics by Region (2019-2024)
8.2 Middle East & Africa Monoclonal Antibody Therapeutics Market Size by Type (2019-2024)
8.3 Middle East & Africa Monoclonal Antibody Therapeutics Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Monoclonal Antibody Therapeutics Market Forecast
10.1 Global Monoclonal Antibody Therapeutics Forecast by Regions (2025-2030)
10.1.1 Global Monoclonal Antibody Therapeutics Forecast by Regions (2025-2030)
10.1.2 Americas Monoclonal Antibody Therapeutics Forecast
10.1.3 APAC Monoclonal Antibody Therapeutics Forecast
10.1.4 Europe Monoclonal Antibody Therapeutics Forecast
10.1.5 Middle East & Africa Monoclonal Antibody Therapeutics Forecast
10.2 Americas Monoclonal Antibody Therapeutics Forecast by Country (2025-2030)
10.2.1 United States Monoclonal Antibody Therapeutics Market Forecast
10.2.2 Canada Monoclonal Antibody Therapeutics Market Forecast
10.2.3 Mexico Monoclonal Antibody Therapeutics Market Forecast
10.2.4 Brazil Monoclonal Antibody Therapeutics Market Forecast
10.3 APAC Monoclonal Antibody Therapeutics Forecast by Region (2025-2030)
10.3.1 China Monoclonal Antibody Therapeutics Market Forecast
10.3.2 Japan Monoclonal Antibody Therapeutics Market Forecast
10.3.3 Korea Monoclonal Antibody Therapeutics Market Forecast
10.3.4 Southeast Asia Monoclonal Antibody Therapeutics Market Forecast
10.3.5 India Monoclonal Antibody Therapeutics Market Forecast
10.3.6 Australia Monoclonal Antibody Therapeutics Market Forecast
10.4 Europe Monoclonal Antibody Therapeutics Forecast by Country (2025-2030)
10.4.1 Germany Monoclonal Antibody Therapeutics Market Forecast
10.4.2 France Monoclonal Antibody Therapeutics Market Forecast
10.4.3 UK Monoclonal Antibody Therapeutics Market Forecast
10.4.4 Italy Monoclonal Antibody Therapeutics Market Forecast
10.4.5 Russia Monoclonal Antibody Therapeutics Market Forecast
10.5 Middle East & Africa Monoclonal Antibody Therapeutics Forecast by Region (2025-2030)
10.5.1 Egypt Monoclonal Antibody Therapeutics Market Forecast
10.5.2 South Africa Monoclonal Antibody Therapeutics Market Forecast
10.5.3 Israel Monoclonal Antibody Therapeutics Market Forecast
10.5.4 Turkey Monoclonal Antibody Therapeutics Market Forecast
10.5.5 GCC Countries Monoclonal Antibody Therapeutics Market Forecast
10.6 Global Monoclonal Antibody Therapeutics Forecast by Type (2025-2030)
10.7 Global Monoclonal Antibody Therapeutics Forecast by Application (2025-2030)
11 Key Players Analysis
11.1 Bayer
11.1.1 Bayer Company Information
11.1.2 Bayer Monoclonal Antibody Therapeutics Product Offered
11.1.3 Bayer Monoclonal Antibody Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Bayer Main Business Overview
11.1.5 Bayer Latest Developments
11.2 F. Hoffmann-La Roche
11.2.1 F. Hoffmann-La Roche Company Information
11.2.2 F. Hoffmann-La Roche Monoclonal Antibody Therapeutics Product Offered
11.2.3 F. Hoffmann-La Roche Monoclonal Antibody Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 F. Hoffmann-La Roche Main Business Overview
11.2.5 F. Hoffmann-La Roche Latest Developments
11.3 Pfizer
11.3.1 Pfizer Company Information
11.3.2 Pfizer Monoclonal Antibody Therapeutics Product Offered
11.3.3 Pfizer Monoclonal Antibody Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Pfizer Main Business Overview
11.3.5 Pfizer Latest Developments
11.4 Sanofi
11.4.1 Sanofi Company Information
11.4.2 Sanofi Monoclonal Antibody Therapeutics Product Offered
11.4.3 Sanofi Monoclonal Antibody Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Sanofi Main Business Overview
11.4.5 Sanofi Latest Developments
11.5 GlaxoSmithKline
11.5.1 GlaxoSmithKline Company Information
11.5.2 GlaxoSmithKline Monoclonal Antibody Therapeutics Product Offered
11.5.3 GlaxoSmithKline Monoclonal Antibody Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 GlaxoSmithKline Main Business Overview
11.5.5 GlaxoSmithKline Latest Developments
11.6 Merck
11.6.1 Merck Company Information
11.6.2 Merck Monoclonal Antibody Therapeutics Product Offered
11.6.3 Merck Monoclonal Antibody Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Merck Main Business Overview
11.6.5 Merck Latest Developments
11.7 Novartis
11.7.1 Novartis Company Information
11.7.2 Novartis Monoclonal Antibody Therapeutics Product Offered
11.7.3 Novartis Monoclonal Antibody Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Novartis Main Business Overview
11.7.5 Novartis Latest Developments
11.8 AbbVie
11.8.1 AbbVie Company Information
11.8.2 AbbVie Monoclonal Antibody Therapeutics Product Offered
11.8.3 AbbVie Monoclonal Antibody Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 AbbVie Main Business Overview
11.8.5 AbbVie Latest Developments
11.9 Amgen
11.9.1 Amgen Company Information
11.9.2 Amgen Monoclonal Antibody Therapeutics Product Offered
11.9.3 Amgen Monoclonal Antibody Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Amgen Main Business Overview
11.9.5 Amgen Latest Developments
11.10 Johnson & Johnson
11.10.1 Johnson & Johnson Company Information
11.10.2 Johnson & Johnson Monoclonal Antibody Therapeutics Product Offered
11.10.3 Johnson & Johnson Monoclonal Antibody Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Johnson & Johnson Main Business Overview
11.10.5 Johnson & Johnson Latest Developments
11.11 Bristol-Myers Squibb Company
11.11.1 Bristol-Myers Squibb Company Company Information
11.11.2 Bristol-Myers Squibb Company Monoclonal Antibody Therapeutics Product Offered
11.11.3 Bristol-Myers Squibb Company Monoclonal Antibody Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Bristol-Myers Squibb Company Main Business Overview
11.11.5 Bristol-Myers Squibb Company Latest Developments
11.12 Biogen
11.12.1 Biogen Company Information
11.12.2 Biogen Monoclonal Antibody Therapeutics Product Offered
11.12.3 Biogen Monoclonal Antibody Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 Biogen Main Business Overview
11.12.5 Biogen Latest Developments
12 Research Findings and Conclusion

Table 1. Monoclonal Antibody Therapeutics Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Humanized Antibody
Table 3. Major Players of Human Mouse Chimeric Antibody
Table 4. Monoclonal Antibody Therapeutics Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 5. Global Monoclonal Antibody Therapeutics Market Size by Type (2019-2024) & ($ Millions)
Table 6. Global Monoclonal Antibody Therapeutics Market Size Market Share by Type (2019-2024)
Table 7. Monoclonal Antibody Therapeutics Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 8. Global Monoclonal Antibody Therapeutics Market Size by Application (2019-2024) & ($ Millions)
Table 9. Global Monoclonal Antibody Therapeutics Market Size Market Share by Application (2019-2024)
Table 10. Global Monoclonal Antibody Therapeutics Revenue by Players (2019-2024) & ($ Millions)
Table 11. Global Monoclonal Antibody Therapeutics Revenue Market Share by Player (2019-2024)
Table 12. Monoclonal Antibody Therapeutics Key Players Head office and Products Offered
Table 13. Monoclonal Antibody Therapeutics Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Monoclonal Antibody Therapeutics Market Size by Regions 2019-2024 & ($ Millions)
Table 17. Global Monoclonal Antibody Therapeutics Market Size Market Share by Regions (2019-2024)
Table 18. Global Monoclonal Antibody Therapeutics Revenue by Country/Region (2019-2024) & ($ millions)
Table 19. Global Monoclonal Antibody Therapeutics Revenue Market Share by Country/Region (2019-2024)
Table 20. Americas Monoclonal Antibody Therapeutics Market Size by Country (2019-2024) & ($ Millions)
Table 21. Americas Monoclonal Antibody Therapeutics Market Size Market Share by Country (2019-2024)
Table 22. Americas Monoclonal Antibody Therapeutics Market Size by Type (2019-2024) & ($ Millions)
Table 23. Americas Monoclonal Antibody Therapeutics Market Size Market Share by Type (2019-2024)
Table 24. Americas Monoclonal Antibody Therapeutics Market Size by Application (2019-2024) & ($ Millions)
Table 25. Americas Monoclonal Antibody Therapeutics Market Size Market Share by Application (2019-2024)
Table 26. APAC Monoclonal Antibody Therapeutics Market Size by Region (2019-2024) & ($ Millions)
Table 27. APAC Monoclonal Antibody Therapeutics Market Size Market Share by Region (2019-2024)
Table 28. APAC Monoclonal Antibody Therapeutics Market Size by Type (2019-2024) & ($ Millions)
Table 29. APAC Monoclonal Antibody Therapeutics Market Size Market Share by Type (2019-2024)
Table 30. APAC Monoclonal Antibody Therapeutics Market Size by Application (2019-2024) & ($ Millions)
Table 31. APAC Monoclonal Antibody Therapeutics Market Size Market Share by Application (2019-2024)
Table 32. Europe Monoclonal Antibody Therapeutics Market Size by Country (2019-2024) & ($ Millions)
Table 33. Europe Monoclonal Antibody Therapeutics Market Size Market Share by Country (2019-2024)
Table 34. Europe Monoclonal Antibody Therapeutics Market Size by Type (2019-2024) & ($ Millions)
Table 35. Europe Monoclonal Antibody Therapeutics Market Size Market Share by Type (2019-2024)
Table 36. Europe Monoclonal Antibody Therapeutics Market Size by Application (2019-2024) & ($ Millions)
Table 37. Europe Monoclonal Antibody Therapeutics Market Size Market Share by Application (2019-2024)
Table 38. Middle East & Africa Monoclonal Antibody Therapeutics Market Size by Region (2019-2024) & ($ Millions)
Table 39. Middle East & Africa Monoclonal Antibody Therapeutics Market Size Market Share by Region (2019-2024)
Table 40. Middle East & Africa Monoclonal Antibody Therapeutics Market Size by Type (2019-2024) & ($ Millions)
Table 41. Middle East & Africa Monoclonal Antibody Therapeutics Market Size Market Share by Type (2019-2024)
Table 42. Middle East & Africa Monoclonal Antibody Therapeutics Market Size by Application (2019-2024) & ($ Millions)
Table 43. Middle East & Africa Monoclonal Antibody Therapeutics Market Size Market Share by Application (2019-2024)
Table 44. Key Market Drivers & Growth Opportunities of Monoclonal Antibody Therapeutics
Table 45. Key Market Challenges & Risks of Monoclonal Antibody Therapeutics
Table 46. Key Industry Trends of Monoclonal Antibody Therapeutics
Table 47. Global Monoclonal Antibody Therapeutics Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 48. Global Monoclonal Antibody Therapeutics Market Size Market Share Forecast by Regions (2025-2030)
Table 49. Global Monoclonal Antibody Therapeutics Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 50. Global Monoclonal Antibody Therapeutics Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 51. Bayer Details, Company Type, Monoclonal Antibody Therapeutics Area Served and Its Competitors
Table 52. Bayer Monoclonal Antibody Therapeutics Product Offered
Table 53. Bayer Monoclonal Antibody Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 54. Bayer Main Business
Table 55. Bayer Latest Developments
Table 56. F. Hoffmann-La Roche Details, Company Type, Monoclonal Antibody Therapeutics Area Served and Its Competitors
Table 57. F. Hoffmann-La Roche Monoclonal Antibody Therapeutics Product Offered
Table 58. F. Hoffmann-La Roche Main Business
Table 59. F. Hoffmann-La Roche Monoclonal Antibody Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 60. F. Hoffmann-La Roche Latest Developments
Table 61. Pfizer Details, Company Type, Monoclonal Antibody Therapeutics Area Served and Its Competitors
Table 62. Pfizer Monoclonal Antibody Therapeutics Product Offered
Table 63. Pfizer Main Business
Table 64. Pfizer Monoclonal Antibody Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 65. Pfizer Latest Developments
Table 66. Sanofi Details, Company Type, Monoclonal Antibody Therapeutics Area Served and Its Competitors
Table 67. Sanofi Monoclonal Antibody Therapeutics Product Offered
Table 68. Sanofi Main Business
Table 69. Sanofi Monoclonal Antibody Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 70. Sanofi Latest Developments
Table 71. GlaxoSmithKline Details, Company Type, Monoclonal Antibody Therapeutics Area Served and Its Competitors
Table 72. GlaxoSmithKline Monoclonal Antibody Therapeutics Product Offered
Table 73. GlaxoSmithKline Main Business
Table 74. GlaxoSmithKline Monoclonal Antibody Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 75. GlaxoSmithKline Latest Developments
Table 76. Merck Details, Company Type, Monoclonal Antibody Therapeutics Area Served and Its Competitors
Table 77. Merck Monoclonal Antibody Therapeutics Product Offered
Table 78. Merck Main Business
Table 79. Merck Monoclonal Antibody Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 80. Merck Latest Developments
Table 81. Novartis Details, Company Type, Monoclonal Antibody Therapeutics Area Served and Its Competitors
Table 82. Novartis Monoclonal Antibody Therapeutics Product Offered
Table 83. Novartis Main Business
Table 84. Novartis Monoclonal Antibody Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 85. Novartis Latest Developments
Table 86. AbbVie Details, Company Type, Monoclonal Antibody Therapeutics Area Served and Its Competitors
Table 87. AbbVie Monoclonal Antibody Therapeutics Product Offered
Table 88. AbbVie Main Business
Table 89. AbbVie Monoclonal Antibody Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 90. AbbVie Latest Developments
Table 91. Amgen Details, Company Type, Monoclonal Antibody Therapeutics Area Served and Its Competitors
Table 92. Amgen Monoclonal Antibody Therapeutics Product Offered
Table 93. Amgen Main Business
Table 94. Amgen Monoclonal Antibody Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 95. Amgen Latest Developments
Table 96. Johnson & Johnson Details, Company Type, Monoclonal Antibody Therapeutics Area Served and Its Competitors
Table 97. Johnson & Johnson Monoclonal Antibody Therapeutics Product Offered
Table 98. Johnson & Johnson Main Business
Table 99. Johnson & Johnson Monoclonal Antibody Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 100. Johnson & Johnson Latest Developments
Table 101. Bristol-Myers Squibb Company Details, Company Type, Monoclonal Antibody Therapeutics Area Served and Its Competitors
Table 102. Bristol-Myers Squibb Company Monoclonal Antibody Therapeutics Product Offered
Table 103. Bristol-Myers Squibb Company Monoclonal Antibody Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 104. Bristol-Myers Squibb Company Main Business
Table 105. Bristol-Myers Squibb Company Latest Developments
Table 106. Biogen Details, Company Type, Monoclonal Antibody Therapeutics Area Served and Its Competitors
Table 107. Biogen Monoclonal Antibody Therapeutics Product Offered
Table 108. Biogen Main Business
Table 109. Biogen Monoclonal Antibody Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 110. Biogen Latest Developments
List of

Figure 1. Monoclonal Antibody Therapeutics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Monoclonal Antibody Therapeutics Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Monoclonal Antibody Therapeutics Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Monoclonal Antibody Therapeutics Sales Market Share by Country/Region (2023)
Figure 8. Monoclonal Antibody Therapeutics Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Monoclonal Antibody Therapeutics Market Size Market Share by Type in 2023
Figure 10. Monoclonal Antibody Therapeutics in Cancer
Figure 11. Global Monoclonal Antibody Therapeutics Market: Cancer (2019-2024) & ($ Millions)
Figure 12. Monoclonal Antibody Therapeutics in Autoimmune Diseases
Figure 13. Global Monoclonal Antibody Therapeutics Market: Autoimmune Diseases (2019-2024) & ($ Millions)
Figure 14. Monoclonal Antibody Therapeutics in Infection
Figure 15. Global Monoclonal Antibody Therapeutics Market: Infection (2019-2024) & ($ Millions)
Figure 16. Monoclonal Antibody Therapeutics in Hematological Diseases
Figure 17. Global Monoclonal Antibody Therapeutics Market: Hematological Diseases (2019-2024) & ($ Millions)
Figure 18. Monoclonal Antibody Therapeutics in Ophthalmological Diseases
Figure 19. Global Monoclonal Antibody Therapeutics Market: Ophthalmological Diseases (2019-2024) & ($ Millions)
Figure 20. Monoclonal Antibody Therapeutics in Others
Figure 21. Global Monoclonal Antibody Therapeutics Market: Others (2019-2024) & ($ Millions)
Figure 22. Global Monoclonal Antibody Therapeutics Market Size Market Share by Application in 2023
Figure 23. Global Monoclonal Antibody Therapeutics Revenue Market Share by Player in 2023
Figure 24. Global Monoclonal Antibody Therapeutics Market Size Market Share by Regions (2019-2024)
Figure 25. Americas Monoclonal Antibody Therapeutics Market Size 2019-2024 ($ Millions)
Figure 26. APAC Monoclonal Antibody Therapeutics Market Size 2019-2024 ($ Millions)
Figure 27. Europe Monoclonal Antibody Therapeutics Market Size 2019-2024 ($ Millions)
Figure 28. Middle East & Africa Monoclonal Antibody Therapeutics Market Size 2019-2024 ($ Millions)
Figure 29. Americas Monoclonal Antibody Therapeutics Value Market Share by Country in 2023
Figure 30. United States Monoclonal Antibody Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 31. Canada Monoclonal Antibody Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 32. Mexico Monoclonal Antibody Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 33. Brazil Monoclonal Antibody Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 34. APAC Monoclonal Antibody Therapeutics Market Size Market Share by Region in 2023
Figure 35. APAC Monoclonal Antibody Therapeutics Market Size Market Share by Type in 2023
Figure 36. APAC Monoclonal Antibody Therapeutics Market Size Market Share by Application in 2023
Figure 37. China Monoclonal Antibody Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 38. Japan Monoclonal Antibody Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 39. Korea Monoclonal Antibody Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 40. Southeast Asia Monoclonal Antibody Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 41. India Monoclonal Antibody Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 42. Australia Monoclonal Antibody Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 43. Europe Monoclonal Antibody Therapeutics Market Size Market Share by Country in 2023
Figure 44. Europe Monoclonal Antibody Therapeutics Market Size Market Share by Type (2019-2024)
Figure 45. Europe Monoclonal Antibody Therapeutics Market Size Market Share by Application (2019-2024)
Figure 46. Germany Monoclonal Antibody Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 47. France Monoclonal Antibody Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 48. UK Monoclonal Antibody Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 49. Italy Monoclonal Antibody Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 50. Russia Monoclonal Antibody Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 51. Middle East & Africa Monoclonal Antibody Therapeutics Market Size Market Share by Region (2019-2024)
Figure 52. Middle East & Africa Monoclonal Antibody Therapeutics Market Size Market Share by Type (2019-2024)
Figure 53. Middle East & Africa Monoclonal Antibody Therapeutics Market Size Market Share by Application (2019-2024)
Figure 54. Egypt Monoclonal Antibody Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 55. South Africa Monoclonal Antibody Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 56. Israel Monoclonal Antibody Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 57. Turkey Monoclonal Antibody Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 58. GCC Country Monoclonal Antibody Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 59. Americas Monoclonal Antibody Therapeutics Market Size 2025-2030 ($ Millions)
Figure 60. APAC Monoclonal Antibody Therapeutics Market Size 2025-2030 ($ Millions)
Figure 61. Europe Monoclonal Antibody Therapeutics Market Size 2025-2030 ($ Millions)
Figure 62. Middle East & Africa Monoclonal Antibody Therapeutics Market Size 2025-2030 ($ Millions)
Figure 63. United States Monoclonal Antibody Therapeutics Market Size 2025-2030 ($ Millions)
Figure 64. Canada Monoclonal Antibody Therapeutics Market Size 2025-2030 ($ Millions)
Figure 65. Mexico Monoclonal Antibody Therapeutics Market Size 2025-2030 ($ Millions)
Figure 66. Brazil Monoclonal Antibody Therapeutics Market Size 2025-2030 ($ Millions)
Figure 67. China Monoclonal Antibody Therapeutics Market Size 2025-2030 ($ Millions)
Figure 68. Japan Monoclonal Antibody Therapeutics Market Size 2025-2030 ($ Millions)
Figure 69. Korea Monoclonal Antibody Therapeutics Market Size 2025-2030 ($ Millions)
Figure 70. Southeast Asia Monoclonal Antibody Therapeutics Market Size 2025-2030 ($ Millions)
Figure 71. India Monoclonal Antibody Therapeutics Market Size 2025-2030 ($ Millions)
Figure 72. Australia Monoclonal Antibody Therapeutics Market Size 2025-2030 ($ Millions)
Figure 73. Germany Monoclonal Antibody Therapeutics Market Size 2025-2030 ($ Millions)
Figure 74. France Monoclonal Antibody Therapeutics Market Size 2025-2030 ($ Millions)
Figure 75. UK Monoclonal Antibody Therapeutics Market Size 2025-2030 ($ Millions)
Figure 76. Italy Monoclonal Antibody Therapeutics Market Size 2025-2030 ($ Millions)
Figure 77. Russia Monoclonal Antibody Therapeutics Market Size 2025-2030 ($ Millions)
Figure 78. Spain Monoclonal Antibody Therapeutics Market Size 2025-2030 ($ Millions)
Figure 79. Egypt Monoclonal Antibody Therapeutics Market Size 2025-2030 ($ Millions)
Figure 80. South Africa Monoclonal Antibody Therapeutics Market Size 2025-2030 ($ Millions)
Figure 81. Israel Monoclonal Antibody Therapeutics Market Size 2025-2030 ($ Millions)
Figure 82. Turkey Monoclonal Antibody Therapeutics Market Size 2025-2030 ($ Millions)
Figure 83. GCC Countries Monoclonal Antibody Therapeutics Market Size 2025-2030 ($ Millions)
Figure 84. Global Monoclonal Antibody Therapeutics Market Size Market Share Forecast by Type (2025-2030)
Figure 85. Global Monoclonal Antibody Therapeutics Market Size Market Share Forecast by Application (2025-2030)

Related Reports

One individual can access, store, display, or archive the report in Excel format but cannot print, copy, or share it. Use is confidential and internal only. License information

One individual can access, store, display, or archive the report in PDF format but cannot print, copy, or share it. Use is confidential and internal only. License information

Up to 10 employees in one region can store, display, duplicate, and archive the report for internal use. Use is confidential and printable. License information

All employees globally can access, print, copy, and cite data externally (with attribution to Bonafide Research). License information

Safe and Secure SSL Encrypted